The TRAP sequence, also known as acardiac twinning is a rare complication that is unique to monochorioinic multiple pregnancies affecting 1% of monochorioinic pregnancies and about 1 in 35000 of all pregnancies. In TRAP, blood flows from the umbilical artery of the pump twin to the umbilical artery of the perfused twin through artery to artery (AA) anastomosis. The perfused twin has poor development of the upper extremities and the normal or pump twin is at risk of a poor perinatal outcome. This is a report of a patient with TRAP sequence diagnosed in the second trimester who was managed conservatively and had a good outcome for the normal twin.
Introduction
The TRAP sequence is a rare complication unique to monochorioinic multiple pregnancies affecting 1% of monochorioinic pregnancies and 1 in 35000 of all pregnancies [1] . These figures are used widely in literature yet they are based on data dating back to 1953 but the incidence appears to be higher now because of use of first trimester ultrasound scan and because of assisted reproductive techniques.
The incidence has been quoted as 2.6% of monochorioinic twins and between 1 in 9500 and 11000 pregnancies in a 2015 study [2] .
In the TRAP sequence the normal twin pumps blood to the perfused twin through the umbilical arteries via the AA anastomosis creating a reversed circulation in this twin. This is possible because there is no functional heart in the acardiac twin which would normally provide forward flow and high systemic pressure. The anomalous twin receives poorly oxygenated blood and this is extracted by the lower part of the body, resulting in further oxygen depleted blood reaching the upper part of the body and eventually in varying degrees of abnormal development of the head, heart and upper limbs [3] . The normal twin is at a risk of high output failure, preterm birth and poor perinatal outcome. The pump twin usually has no congenital malformations but has an increased mortality rate between 35 and 50% [4, 5] . The abnormal twin may appear as a heterogeneous mass on ultrasound scan or as intrauterine foetal demise as in the case presented.
Patient and observation
Mrs. CD, a 27 year old Para 2 gravida 3 patient was referred from a district hospital with a diagnosis of multiple pregnancy with intrauterine demise of a co-twin at 26 weeks gestation. She had no complaints at presentation and had not experienced excessive symptoms of pregnancy earlier on in the pregnancy. She believed her abdomen was growing at a normal rate and she had felt quickening a few weeks before. The pregnancy was planned and she booked the pregnancy at the district hospital a week prior to presentation. She had normal vaginal deliveries of her first 2 children with no antepartum or intrapartum complications but was diagnosed with chronic hypertension during her 6 week post-natal visit after delivery of her second child. She was started on enalapril and nifedipine but she defaulted treatment 2 months before falling pregnant. Her method of contraception was a combined oral contraceptive (Lofeminal) which she stopped taking one month before she fell pregnant. Nifedipine and methyldopa were commenced at 26 weeks gestation when the blood pressure was noted to be elevated and the blood pressure was well controlled have aided in the diagnosis of cardiac failure in the pump twin [7] .
Unfortunately, we were unable to measure the intrauterine size of the acardiac twin to allow us to estimate the relative size of the acardiac twin compared to the pump twin. The ratio of the weight of the acardiac twin to that of the pump twin was 0.46. Usually if the ratio of the weight of the acardiac to the pump twin is greater than 0.7, the risk of preterm birth is higher [8] . Other options for management not immediately available to us were laser, bipolar and radiofrequency coagulation of the umbilical cord as well as amnioreduction had the pregnancy been complicated by polyhydramnios. These procedures for in utero therapy are available at a small number of institutions in the developed world [7, 8] . 
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